Navigation Links
AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
Date:6/20/2008

NEW YORK, June 20 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), announced today it has retained Strategic Growth International, Inc. ("SGI"), a global investor relations firm, to assist the Company in growing its financial market presence. SGI will assist the Company in establishing a stronger understanding of the investment opportunity AMDL represents while increasing the Company's awareness across global investment communities.

Gary Dreher, CEO of AMDL, commented, "As we continue building AMDL into a world-class pharmaceutical company we feel strong communications is imperative to our success. SGI has a strong reputation with an exceptional team and we're excited to have them as a partner to communicate our corporate story, the great progress we're making with new products and technologies in the U.S., China, and other global markets, and most important, how we intend to meet our stated financial targets of doubling annual sales consecutively over the next 3 years."

SGI Co-Founder Rich Cooper also commented saying, "We believe a strong investment story exists with AMDL and we're excited the company has chosen us to support their IR efforts. Through our combined efforts we will focus on achieving a fair and sustainable market valuation for AMDL while enhancing their reputation with investors, analysts, and the financial media."

Founded in 1989, SGI is headed by Richard E. Cooper and Stanley Altschuler, both long-time and highly-respected Wall Street veterans. Prior to his co-founding SGI, Mr. Cooper was a Managing Director at Salomon Brothers for five of his 14 years at the firm. Mr. Altschuler owned and managed a New York-based brokerage firm.

About AMDL

AMDL, Inc. is a global specialty pharmaceutical company. The Company is headquartered in Tustin, California with operations in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products currently in China. The company employs approximately 320 people in the U.S. and China. More information about AMDL and its products can be obtained at http://www.amdl.com.

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to our ability to successfully complete Phase III clinical trials and secure regulatory approval of our current or future drug-delivery system and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.

AMDL Contact: Investor Relations Contact:

Kristine Szarkowitz Strategic Growth International, Inc.

Director-Investor Relations Richard E. Cooper - rcooper@sgi-ir.com

kszarkowitz@amdl.com Cass Almendral - cass@sgi-ir.com

(206) 310-5323 (212) 838-1444/ http://www.sgi-ir.com


'/>"/>
SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SPO Medical Retains American Capital Ventures for Investor Relations Services
2. Interleukin Genetics Retains Top Life Science Communications Firms
3. Dragon retains leading investor relations firm
4. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
5. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
6. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
7. Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.
8. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
9. Paul Capital Healthcare Leads Panel on Strategic Financing
10. AHIMA Reacts in Support of NAHITs New Strategic and Operating Framework
11. Official Signing Ceremony for WIBP Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading ... the Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio ... and clinical trial team. , Using the CONSULT module, patients and physicians can schedule ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... ... 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona combed ... pleural mesothelioma. Their findings are the subject of a new article on the Surviving ... signposts in the blood, lung fluid or tissue of mesothelioma patients that can help ...
Breaking Biology Technology:
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):